Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

AZD5582 acetate (1258392-53-8 free base)

Catalog No. T14378L

AZD5582 acetate is an inhibitor of IAPs, which binds to the BIR3 domains cIAP1, cIAP2, and XIAP with IC50s of 15, 21, and 15 nM, respectively. AZD5582 induces apoptosis.

AZD5582 acetate (1258392-53-8 free base)

AZD5582 acetate (1258392-53-8 free base)

Purity: 97.76%
Catalog No. T14378L
AZD5582 acetate is an inhibitor of IAPs, which binds to the BIR3 domains cIAP1, cIAP2, and XIAP with IC50s of 15, 21, and 15 nM, respectively. AZD5582 induces apoptosis.
Pack SizePriceAvailabilityQuantity
2 mg$89Backorder
5 mg$128Backorder
10 mg$189Backorder
1 mL x 10 mM (in DMSO)$275Backorder
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Purity:97.76%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
AZD5582 acetate is an inhibitor of IAPs, which binds to the BIR3 domains cIAP1, cIAP2, and XIAP with IC50s of 15, 21, and 15 nM, respectively. AZD5582 induces apoptosis.
Targets&IC50
CIAP1:15 nM, XIAP:15 nM, CIAP2:21 nM
In vitro
AZD5582 (20 nM; 48 hours) inhibited cell viability by cooperation with IFNγ or viral double-stranded RNA (dsRNA) in H1975 NSCLC cells[2]. AZD5582 (20 nM; 48 hours) involves in apoptosis due to induction of cell death and active caspase-3/ -8 activities by AZD5582 and IFNγ co-treatment in HCC827 NSCLC cells[2]. AZD5582 (20 nM; 17 or 25 hours) down-regulates cIAP-1, activates RIPK1( upstream regulator of caspase-8), and triggers the activation of extrinsic (caspase-8) and intrinsic (caspase-9) apoptosis pathways, causing the cleavage of caspase-3 and caspase-7[2].
In vivo
AZD5582 (intravenous injection; 0.1-3.0 mg/kg; once a week; 2 weeks) causes degradation of cIAP1 and caspase 3 cleavage in tumor cells, and after a two-week treatment, the tumors largely resolved. When the mice are given a medium dose (0.5 mg/kg) of AZD5582, cIAP1 degrades after administration, but it takes a while time to reach apoptosis-inducing effect[1].
Chemical Properties
Molecular Weight1075.36
FormulaC60H82N8O10
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 55 mg/ml (51.15 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM0.9299 mL4.6496 mL9.2992 mL46.4961 mL
5 mM0.1860 mL0.9299 mL1.8598 mL9.2992 mL
10 mM0.0930 mL0.4650 mL0.9299 mL4.6496 mL
20 mM0.0465 mL0.2325 mL0.4650 mL2.3248 mL
50 mM0.0186 mL0.0930 mL0.1860 mL0.9299 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy AZD5582 acetate (1258392-53-8 free base) | purchase AZD5582 acetate (1258392-53-8 free base) | AZD5582 acetate (1258392-53-8 free base) cost | order AZD5582 acetate (1258392-53-8 free base) | AZD5582 acetate (1258392-53-8 free base) chemical structure | AZD5582 acetate (1258392-53-8 free base) in vivo | AZD5582 acetate (1258392-53-8 free base) in vitro | AZD5582 acetate (1258392-53-8 free base) formula | AZD5582 acetate (1258392-53-8 free base) molecular weight